- All
- #InspiredByLife
- Bioeconomy
- Biosimilars
- BREXIT
- Cell & Gene Therapies
- Circular Economy
- Climate Change
- COVID-19
- Factsheet
- Genome editing
- HEALTHCARE BIOTECH
- INDUSTRIAL BIOTECH
- Innovation
- Intellectual Property
- Interview
- Jobs & Growth
- NATIONAL ASSOCIATIONS
- News
- Other
- Patient Bio-Forum
- Position Paper
- Press release
- Public Procurement
- Regulatory Efficiency
- Report
- SME
- SME Platform
- WHAT IF
- White paper
June 29, 2021
We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
May 26, 2021
May 20, 2021
The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
May 5, 2021
EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.
May 5, 2021
EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.
May 5, 2021
EuropaBio Statement – Vaccine production scale up: International collaboration remains the key.
April 16, 2021
March 5, 2021
March 1, 2021
Read EuropaBios interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi, on the occasion of Rare Disease Week 2021.
February 24, 2021
On February 24th, EuropaBio submitted its feedback to the HERA Consultation.
February 4, 2021
EuropaBio welcomes the European Commission’s plan to begin a discussion with stakeholders to develop the EHDS.
January 29, 2021
EuropaBio welcomes the European Health Union plan. The EU has indeed a critical role to play in public health and better crisis preparedness to address serious cross-border health threats and improving crisis management capacity.
December 20, 2020
EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.
September 24, 2020
Genome editing is an advance in biological tools with the potential for a wide range of applications.
August 24, 2020
This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
